News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cholesterol-Drug Developer Aegerion Pharmaceuticals, Inc. Revives Plan for $86.3M IPO



8/11/2010 7:10:01 AM

Wall Street Journal -- Aegerion Pharmaceuticals Inc. re-registered to hold an $86.3 million initial public offering of shares, after abandoning a similar plan as the stock-market plunged in late 2008.



comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES